NVCT
NuvectisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
NVCT vs peer average
56/100
NVCT vs. peer average (C vs. C)
Grade spread
A 3 · B 1 · D 3 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CABA is the first available peer comparator.
Clinical-stage small-cap biotech peer with similar financing and catalyst-driven volatility, though therapeutic focus is not oncology and therefore peer fit is only moderate.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NVCT
Nuvectis
CABA
Cabaletta Bio
Grade
C
B
Momentum
88
89
Value
41
41
Sentiment
35
47
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs CABA
NVCT / CABA
Grade Position
In line
NVCT vs. peer average (C vs. C)
56/100
Momentum
88
CABAValue
41
NVCTSentiment
35
CABARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NVCT
CABA is the first peer returned for this comparison set.